Your session is about to expire
← Back to Search
PRP Injections for Shoulder Osteoarthritis
Study Summary
This trial will compare treatments for glenohumeral OA: physical activity, injections, medications, low-dose PRP, high-dose PRP and saline injections. Results will determine which is most effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 100 years old.I have had pain for over 3 months despite trying treatments like physical therapy.I have ongoing cervical health issues that aren't managed.I felt better temporarily after getting a joint injection for diagnosis.I have had pain for over 3 months that hasn't improved with treatments like physical therapy.I have had a platelet-rich plasma injection before.I have recent fractures or severe deformities.My shoulder pain from arthritis or cartilage loss averages 5/10 or more.I have not had a steroid injection in the last 3 months.I do not have any uncontrolled illnesses like diabetes or autoimmune diseases.I have taken Plavix before.I can stop taking NSAIDs 2 weeks before and 1 month after an injection.I felt better temporarily after getting a joint injection for diagnosis.
- Group 1: Low-dose PRP
- Group 2: High-dose PRP
- Group 3: Saline control
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this medical trial accept subjects under 45 years of age?
"This medical study is open to individuals aged 18 and over, up until their centenarian year."
What safety concerns should be taken into account when utilizing Low-dose PRP treatments?
"As this is a Phase 4 trial, indicating that Low-dose PRP has been approved thus far and so it was given a safety rating of 3."
Who meets the criteria necessary to join this trial?
"To be eligible for this research study, patients should possess shoulder osteoarthritis and must fall between 18-100 years old. The total expected participants is 135 individuals."
Are any additional participants being admitted to participate in this research?
"According to the data published on clinicaltrials.gov, this research is not currently accepting patients due to its most recent update being made at the end of December 2022. Nevertheless, there are 594 different medical trials actively recruiting participants presently."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger